作为医疗器械领域开发难度最高、结构最精密、容错率为零的产品之一，人工心脏一直被誉为“医疗器械皇冠上的明珠”，但过去这个领域被全球巨头雅培、强生等医疗企业牢牢把持，构筑了极高的技术与商业壁垒。
We distribute grants based on open, data-driven inputs, and our model is co-developed
，详情可参考体育直播
Additionally there would need to be a clear specification of how types
“정파적 우편향 사상, 신앙과 연결도 신자 가스라이팅도 안돼”